FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 359:2045-2047 November 6, 2008 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article by Hoshida, Y. PubMed Citation

Although the treatment of hepatocellular carcinoma is evolving, hepatic resection remains the treatment of choice for many patients. Resection is associated with a 5-year survival rate of 50% but also a 70% recurrence rate.^1,2,3 Thus, for most patients, resection is not a cure. Recurrence of hepatocellular carcinoma after resection or local ablation with heat generated by high-frequency radio waves can be classified as early or late. Early recurrence occurs within weeks or months after treatment and has been attributed to either incomplete initial treatment or micrometastases within the liver but outside the treated field. Late recurrence, defined as recurrence more . . . [Full Text of this Article]

Source Information

This article (10.1056/NEJMe0807581) was published at www.nejm.org on October 15, 2008.

From the Department of Medicine, University of Toronto, Toronto.

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.